Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
Business Wire•21/10/2026•06:00 ET
0
Key Highlights
- ➤FY 2026 adjusted diluted EPS guidance raised to at least $29.00
- ➤FY 2026 operating cash flow guidance raised to at least $6.5 billion
- ➤3Q 2026 operating revenue reached $50.4 billion, up 0.7% year over year
- ➤Carelon operating gain rose 17% year over year to $0.9 billion
- ➤Medical membership declined 487 thousand year over year to approximately 44.9 million
Expert Statements
Gail K. Boudreaux, President and Chief Executive Officer of Elevance Health
“Elevance Health's third quarter results reflect stronger execution across our diversified portfolio and underscore the earnings power of the business. We are raising our 2026 earnings outlook and remain confident in delivering at least 12% growth in adjusted diluted earnings per share in 2027 from our higher earnings baseline of at least $26.75. By bringing together the capabilities of our Health Benefits business and Carelon, we are improving the healthcare experience, strengthening our competitive advantage, and creating long-term value for our shareholders.”
Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
3Q 2026 operating revenue of $50.4 billion, up 0.7% from 3Q 2025
Get started
Create a free account to read the full story.